Searchable abstracts of presentations at key conferences in endocrinology

ea0090rc7.4 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2023

Effects of prolactin excess and treatment with cabergoline on bone mineral density and fracture risk in men

Del Vecchio Guendalina , Sorice Federica , Scairati Roberta , Pirchio Rosa , Meglio Sara Di , Pivonello Rosario , Colao Annamaria , Aurie mma Renata Simona

Purpose: The present study aims to investigate the effects of hyperprolactinemia (HPRL) and its pharmacological control with Cabergoline (CAB) on the risk of fractures in male patients affected by prolactinoma.Methods: Observational single-center study was conducted on 39 male patients (median age 49±12,4 y) with prolactinoma, including 37 with macroprolactinoma and 2 with empty sellae. In patients PRL levels at diagnosis (PRL 0’), PRL at evalu...

ea0090p413 | Pituitary and Neuroendocrinology | ECE2023

Sleep Disorders And Osas Risk in Patients with Prolactinoma: A Single Center Experience

Del Vecchio Guendalina , Sorice Federica , Scairati Roberta , Pirchio Rosa , Di Meglio Sara , Pivonello Rosario , Colao Annamaria , Simona Auriemma Renata

Purpose: Dopaminergic system is implicated in the development of sleep disorders, and dopaminergic agents are used in clinical practice to treat daytime sleepiness and sleep disorders. The present study aimed at investigating the effects of hyperprolactinemia and its control with dopamine-agonists (DA) on sleep quality, excessive daytime sleepiness (ESS) and risk of obstructive sleep apnea syndrome (OSAS) in prolactinomas.Methods: A single-centre study w...

ea0099ep1293 | Late Breaking | ECE2024

The impact of metabolic and hormonal alterations on sexual and psychological function in women with polycystic ovary syndrome

Verde Nunzia , Sorice Federica , Scairati Roberta , de Angelis Cristina , Garifalos Francesco , Menafra Davide , de Fraia Antonio , Santella Luigi , Mazzarella Alessandro , Simona Auriemma Renata , Colao Annamaria , Pivonello Rosario

The current study evaluated the impact of metabolic and hormonal alterations on sexual and psychological function in women with Polycystic Ovary Syndrome (PCOS). Fifty consecutive women aged 24.16±5.97 years with a diagnosis of PCOS were recruited; metabolic and hormonal parameters were measured and questionnaires related to sexual function (Female Sexual Function Index-FSFI) and psychological traits (Middlesex Hospital Questionnaire-MHQ, Body Uneasiness Test A and B-BUT A ...